Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 127 articles: HTML format

Single Articles

July 2022
1. CHENG X, Zeng W, Liu Y, Song Z, et al
   Impact of Lymph Node Dissection on Survival and Tumor Recurrence for Patients with Resected cT1-2N0 Small Cell Lung Cancer.
   Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12215.
   PubMed     Abstract available
   
   
   
2. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
   Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
   Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12239.
   PubMed     Abstract available
   
   
   
3. BURCH AE, Wong JH, Irish WD
   ASO Author Reflections: Identifying and Understanding Disparities in Access to Surgery: Operable Lung Cancer in North Carolina.
   Ann Surg Oncol. 2022 Jul 12. pii: 10.1245/s10434-022-12179.
   PubMed    
   
   
   June 2022
4. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
   ASO Visual Abstract: Clinical Impact of Sarcopenia 1 Year after Surgery in Patients with Early-Stage Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2022 Jun 28. pii: 10.1245/s10434-022-12068.
   PubMed    
   
   
   
5. USHITANI Y, Shimada Y, Yamada Y, Kudo Y, et al
   Clinical Impact of Sarcopenia 1 Year After Surgery for Patients with Early-Stage Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2022 Jun 21. pii: 10.1245/s10434-022-11999.
   PubMed     Abstract available
   
   
   
6. USHITANI Y, Shimada Y
   ASO Author Reflections: Management to Prevent Postoperative Sarcopenia in Patients with Lung Cancer.
   Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12026.
   PubMed    
   
   
   
7. BAILEY J, Van Haren RM
   Complementary Roles of Screening and Nodule Programs for Early Detection of Lung Cancer in Diverse Populations.
   Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11943.
   PubMed    
   
   
   
8. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
   ASO Visual Abstract: Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2022 Jun 3. pii: 10.1245/s10434-022-11907.
   PubMed    
   
   
   
9. IWASAKI M, Ishihara S, Okada S, Shimegi R, et al
   Prognostic Impact of Using Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Resectable Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2022 Jun 2. pii: 10.1245/s10434-022-11835.
   PubMed     Abstract available
   
   
   May 2022
10. DONINGTON JS
    Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care.
    Ann Surg Oncol. 2022 May 27. pii: 10.1245/s10434-022-11915.
    PubMed    
    
    
    
11. IWASAKI M, Ishihara S, Inoue M
    ASO Author Reflections: Clinical Significance of Combined Plasma Fibrinogen Level and Neutrophil-to-Lymphocyte Ratio in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2022 May 25. pii: 10.1245/s10434-022-11886.
    PubMed    
    
    
    
12. KUO SW, Chen PH, Lu TP, Chen KC, et al
    ASO Visual Abstract: Primary Tumor Resection for Stage IV Non-Small-Cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11687.
    PubMed    
    
    
    
13. KHAN TM, Verbus EA, Gandhi S, Heymach JV, et al
    Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR).
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11627.
    PubMed    
    
    
    
14. TEKE ME, Sarvestani AL, Hernandez JM, Fernando HC, et al
    A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC).
    Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11584.
    PubMed    
    
    
    
15. DONINGTON JS
    The Increasing Role of Surgery in Comprehensive Treatment of Advanced Non-small Cell Lung Cancer with Targetable Mutations.
    Ann Surg Oncol. 2022 May 6. pii: 10.1245/s10434-022-11764.
    PubMed    
    
    
    
16. DHANASOPON AP, Boffa DJ
    Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery.
    Ann Surg Oncol. 2022 May 3. pii: 10.1245/s10434-022-11797.
    PubMed    
    
    
    
17. YUN JK, Kim YH
    ASO Author Reflections: Could VAMLA be a Therapeutic Strategy in Selected Patients with Left-sided NSCLC?
    Ann Surg Oncol. 2022;29:2840-2841.
    PubMed    
    
    
    April 2022
18. KUO SW, Chen PH, Lu TP, Chen KC, et al
    Correction to: Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11714.
    PubMed    
    
    
    
19. CUI C, Lian B, Zhang X, Wu D, et al
    An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11670.
    PubMed     Abstract available
    
    
    March 2022
20. CHEN PH, Kuo SW, Chen JS
    ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor.
    Ann Surg Oncol. 2022 Mar 21. pii: 10.1245/s10434-022-11487.
    PubMed    
    
    
    
21. KUO SW, Chen PH, Lu TP, Chen KC, et al
    Primary Tumor Resection for Stage IV Non-small-cell Lung Cancer Without Progression After First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Retrospective Case-Control Study.
    Ann Surg Oncol. 2022 Mar 7. pii: 10.1245/s10434-022-11483.
    PubMed     Abstract available
    
    
    
22. KEPENEKIAN V, Peron J, You B, Bonnefoy I, et al
    Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
    Ann Surg Oncol. 2022;29:2104-2113.
    PubMed     Abstract available
    
    
    
23. KEPENEKIAN V, Peron J, You B, Glehen O, et al
    ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection.
    Ann Surg Oncol. 2022;29:2114-2115.
    PubMed    
    
    
    February 2022
24. WANKHEDE D, Grover S
    ASO Visual Abstract: Outcomes Following Curative Metastasectomy for Patients with Malignant Melanoma: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022 Feb 21. pii: 10.1245/s10434-022-11391.
    PubMed    
    
    
    
25. WANG ZN, Jiang XB, Lu J, Guo XY, et al
    Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study.
    Ann Surg Oncol. 2022 Feb 18. pii: 10.1245/s10434-022-11365.
    PubMed     Abstract available
    
    
    
26. LIU C, Wang W, Mei J, Zhu Y, et al
    Uniportal Thoracoscopic Single-Direction Basal Subsegmentectomy (Left S10a+ci): Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2022;29:1389-1391.
    PubMed     Abstract available
    
    
    January 2022
27. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
    ASO Visual Abstract: Survival After Adrenalectomy for Metastatic Lung Cancer.
    Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-021-11282.
    PubMed    
    
    
    
28. YUN JK, Yoo S, Lee GD, Choi S, et al
    Comparison of Long-Term Outcomes Between Minimally Invasive Pulmonary Resection With and Without Video-Assisted Mediastinoscopic Lymphadenectomy for Left-Sided Lung Cancer.
    Ann Surg Oncol. 2022 Jan 13. pii: 10.1245/s10434-021-11191.
    PubMed     Abstract available
    
    
    
29. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients With Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2022 Jan 8. pii: 10.1245/s10434-021-11024.
    PubMed     Abstract available
    
    
    
30. LEECH MM, Weiss JE, Markey C, Loehrer AP, et al
    Influence of Race, Insurance, Rurality, and Socioeconomic Status on Equity of Lung and Colorectal Cancer Care.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11160.
    PubMed     Abstract available
    
    
    
31. KRUMEICH LN, Roses RE, Kuo LE, Lindeman BM, et al
    Survival After Adrenalectomy for Metastatic Lung Cancer.
    Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11192.
    PubMed     Abstract available
    
    
    
32. KARUSH JM
    Segmentectomy...Because We Can or Because We Should?
    Ann Surg Oncol. 2022;29:28-29.
    PubMed    
    
    
    
33. DAI W, Mu Y, Chang S, Wu Z, et al
    ASO Author Reflections: Using Patient-Reported Outcomes to Compare Thoracoscopic Segmentectomy and Lobectomy.
    Ann Surg Oncol. 2022;29:557-558.
    PubMed    
    
    
    
34. LI Z, He W, Wang C
    ASO Author Reflections: A Simple Method to Predict Risk Factors of Complications After Pneumonectomy.
    Ann Surg Oncol. 2022;29:570-571.
    PubMed    
    
    
    December 2021
35. HANDA Y, Tsutani Y, Okada M
    ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function.
    Ann Surg Oncol. 2021;28:8356-8357.
    PubMed    
    
    
    
36. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Postoperative Pulmonary Function After Complex Segmentectomy.
    Ann Surg Oncol. 2021;28:8347-8355.
    PubMed     Abstract available
    
    
    
37. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
    Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:8398-8411.
    PubMed     Abstract available
    
    
    
38. LEE G, Yoon S, Ahn B, Kim HR, et al
    ASO Visual Abstract: Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
39. CHIANG XH, Lu TP, Hsieh MS, Tsai TM, et al
    ASO Visual Abstract: Thoracoscopic Wedge Resection Versus Segmentectomy for cT1N0 Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
40. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    ASO Visual Abstract: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
41. SHIGEFUKU S
    Reply to "Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients" by Guowei Che et al.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    
42. WANG Y, Che G
    Ground Glass Opacity (GGO) Predicts Improved Survival of Pathologic Stage I Lung Adenocarcinoma Patients.
    Ann Surg Oncol. 2021;28.
    PubMed    
    
    
    November 2021
43. SUN C, Anraku M, Nakajima J
    ASO Author Reflections: An Evolving Skeletal Muscle Profiling-Towards Precise Host Phenotype and Prognostic Stratification in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11025.
    PubMed    
    
    
    
44. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    ASO Visual Abstract: Combination of Skeletal Muscle Mass and Density Predicts Postoperative Complications and Survival of Patients with Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11071.
    PubMed    
    
    
    
45. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
    ASO Visual Abstract: Non-small Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection-can Chemoradiotherapy Offer Similar Survival?
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11061.
    PubMed    
    
    
    
46. JOHANSON H, Okereke I
    The Importance of Clinical Decision-Making in Surgical Planning for Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 8. pii: 10.1245/s10434-021-11027.
    PubMed    
    
    
    
47. DAI W, Chang S, Pompili C, Qiu B, et al
    Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small-cell Lung Cancer.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10946.
    PubMed     Abstract available
    
    
    
48. LEE G, Yoon S, Ahn B, Kim HR, et al
    Blood Vessel Invasion Predicts Postoperative Survival Outcomes and Systemic Recurrence Regardless of Location or Blood Vessel Type in Patients with Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:7279-7290.
    PubMed     Abstract available
    
    
    October 2021
49. VAN JOOLINGEN WH, Rasing MJA, Peters M, van Lindert ASR, et al
    Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?
    Ann Surg Oncol. 2021 Oct 30. pii: 10.1245/s10434-021-10982.
    PubMed     Abstract available
    
    
    
50. DAI W, Chang S, Pompili C, Qiu B, et al
    ASO Visual Abstract: Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Oct 23. pii: 10.1245/s10434-021-10963.
    PubMed    
    
    
    
51. HANDA Y, Tsutani Y, Okada M
    Reply to "Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?" by Han-Yu Deng.
    Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10684.
    PubMed    
    
    
    
52. SHI Y, Wu S, Ma S, Lyu Y, et al
    Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
    Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10857.
    PubMed     Abstract available
    
    
    
53. ZHU Y, Xia L, Liu C, Lin F, et al
    Uniportal Single-Direction Thoracoscopic Right S9 Segmentectomy: Trans-Inferior-Pulmonary-Ligament Approach.
    Ann Surg Oncol. 2021;28:6407.
    PubMed     Abstract available
    
    
    
54. NISHINO T, Toba H, Yoshida T, Inoue S, et al
    Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer.
    Ann Surg Oncol. 2021;28:6398-6406.
    PubMed     Abstract available
    
    
    
55. LEPPELMANN KS, Levesque VM, Bunck AC, Cahalane AM, et al
    Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study.
    Ann Surg Oncol. 2021;28:5829-5839.
    PubMed     Abstract available
    
    
    
56. LI S, Qiao S, Li N, Zhu X, et al
    MiR-744 Functions as an Oncogene Through Direct Binding to c-Fos Promoter and Facilitates Non-small Cell Lung Cancer Progression.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10688.
    PubMed     Abstract available
    
    
    
57. LEPPELMANN KS, Fintelmann FJ
    ASO Author Reflections: Percutaneous Image-Guided Ablation and Multi-modality Management of Lung Metastases.
    Ann Surg Oncol. 2021;28:5840-5841.
    PubMed    
    
    
    September 2021
58. WEI X, Yu H, Dai W, Mu Y, et al
    Correction to: Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10798.
    PubMed    
    
    
    
59. HANDA Y, Tsutani Y, Okada M
    ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection.
    Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10037.
    PubMed    
    
    
    August 2021
60. DENG HY
    Lobe-Specific Lymph Node Dissection for Lung Cancer: Is it Still Feasible?
    Ann Surg Oncol. 2021 Aug 21. pii: 10.1245/s10434-021-10671.
    PubMed    
    
    
    
61. WANG C, Wang S, Li Z, He W, et al
    ASO Visual Abstract: A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Aug 3. pii: 10.1245/s10434-021-10542.
    PubMed    
    
    
    
62. ZHAO ZR, Liu DH, Wang YZ, Sun XS, et al
    Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4542-4550.
    PubMed     Abstract available
    
    
    
63. ZHAO ZR, Long H
    ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma.
    Ann Surg Oncol. 2021;28:4551-4552.
    PubMed    
    
    
    July 2021
64. WANG C, Wang S, Li Z, He W, et al
    A Multiple-Center Nomogram to Predict Pneumonectomy Complication Risk for Non-Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Jul 28. pii: 10.1245/s10434-021-10504.
    PubMed     Abstract available
    
    
    
65. HANDA Y, Tsutani Y, Mimae T, Miyata Y, et al
    Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer.
    Ann Surg Oncol. 2021 Jul 3. pii: 10.1245/s10434-021-10020.
    PubMed     Abstract available
    
    
    
66. FU X, Wang F, Su X, Luo G, et al
    Endobronchial Ultrasound Improves Evaluation of Recurrent Laryngeal Nerve Lymph Nodes in Esophageal Squamous Cell Carcinoma Patients.
    Ann Surg Oncol. 2021;28:3930-3938.
    PubMed     Abstract available
    
    
    
67. KIM IA, Hur JY, Kim HJ, Park JH, et al
    Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3983-3993.
    PubMed     Abstract available
    
    
    
68. KIM IA, Kim WS, Lee KY
    ASO Author Reflections: CTNNB1 and Fusion Genes as Predictors for Recurrence in Resected Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3994-3995.
    PubMed    
    
    
    June 2021
69. CHIANG XH, Lin MW, Hsu HH, Chen JS, et al
    ASO Author Reflection: Comparing Wedge Resection and Segmentectomy as the Appropriate Surgical Method in cT1N0 Lung Cancer.
    Ann Surg Oncol. 2021 Jun 5. pii: 10.1245/s10434-021-10214.
    PubMed    
    
    
    
70. NAKAMURA A, Kondo N, Nakamichi T, Hashimoto M, et al
    Complications and Predictive Factors for Air Leak > 10 Days with Neoadjuvant Chemotherapy Followed by Pleurectomy/Decortication for Malignant Pleural Mesothelioma.
    Ann Surg Oncol. 2021;28:3057-3065.
    PubMed     Abstract available
    
    
    
71. MATSUBARA T, Okamoto T
    ASO Author Reflections: The C-Reactive Protein (CRP)-Albumin Ratio May Be Useful as the Most Prognostic Index Among the Immuno-nutritional Parameters Using CRP and Albumin for Resected NSCLC.
    Ann Surg Oncol. 2021;28:3055-3056.
    PubMed    
    
    
    May 2021
72. WEI X, Yu H, Shi Q
    ASO Author Reflections: Using Patient-Reported Outcomes to Evaluate Surgical Approaches for Locally Advanced Lung Cancer.
    Ann Surg Oncol. 2021 May 15. pii: 10.1245/s10434-021-10018.
    PubMed    
    
    
    
73. LOTZE MT, Dhupar R
    ASO Author Reflection: Viruses, the Lung, and Thoracic Neoplasms: Breaking Bad.
    Ann Surg Oncol. 2021;28:2728-2729.
    PubMed    
    
    
    April 2021
74. MIMAE T, Saji H, Nakamura H, Okumura N, et al
    Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
    Ann Surg Oncol. 2021 Apr 26. pii: 10.1245/s10434-021-09835.
    PubMed     Abstract available
    
    
    
75. WEI X, Yu H, Dai W, Mu Y, et al
    Patient-Reported Outcomes of Video-Assisted Thoracoscopic Surgery Versus Thoracotomy for Locally Advanced Lung Cancer: A Longitudinal Cohort Study.
    Ann Surg Oncol. 2021 Apr 20. pii: 10.1245/s10434-021-09981.
    PubMed     Abstract available
    
    
    
76. GOOSEMAN MR, Brunelli A
    Intraoperative Lymph Node Management During Non-small Cell Lung Cancer Surgery.
    Ann Surg Oncol. 2021 Apr 16. pii: 10.1245/s10434-021-10039.
    PubMed    
    
    
    
77. KANTOR T, Wakeam E
    Landmark Trials in the Surgical Management of Mesothelioma.
    Ann Surg Oncol. 2021;28:2037-2047.
    PubMed     Abstract available
    
    
    
78. CHEN D, Ding Q, Wang W, Wang X, et al
    Characterization of Extracapsular Lymph Node Involvement and Its Clinicopathological Characteristics in Stage II-IIIA Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2088-2098.
    PubMed     Abstract available
    
    
    
79. KAGIMOTO A, Tsutani Y, Okada M
    ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection.
    Ann Surg Oncol. 2021;28:2076-2077.
    PubMed    
    
    
    
80. KAGIMOTO A, Tsutani Y, Handa Y, Mimae T, et al
    Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2068-2075.
    PubMed     Abstract available
    
    
    March 2021
81. MIMAE T, Saji H, Okada M
    ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?
    Ann Surg Oncol. 2021 Mar 23. pii: 10.1245/s10434-021-09860.
    PubMed    
    
    
    
82. ZENG Q, Li J, Tan F, Sun N, et al
    Development and Validation of a Nomogram Prognostic Model for Resected Limited-Stage Small Cell Lung Cancer Patients.
    Ann Surg Oncol. 2021 Mar 2. pii: 10.1245/s10434-020-09552.
    PubMed     Abstract available
    
    
    February 2021
83. TSUDAKA S, Yamamoto H, Sato H, Toyooka S, et al
    ASO Author Reflections: Impact of the Postoperative Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small Cell Lung Cancer Treated with Induction Chemoradiotherapy Followed by Surgery.
    Ann Surg Oncol. 2021 Feb 25. pii: 10.1245/s10434-021-09699.
    PubMed    
    
    
    
84. TSUDAKA S, Yamamoto H, Sato H, Katsui K, et al
    Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy.
    Ann Surg Oncol. 2021 Feb 25. pii: 10.1245/s10434-021-09690.
    PubMed     Abstract available
    
    
    
85. BATCHELOR T, Hasan J, Macbeth F, Shackcloth M, et al
    Randomised Controlled Trial Evidence Questions the Assumption that Pulmonary Metastasectomy Benefits Patients with Colorectal Cancer.
    Ann Surg Oncol. 2021 Feb 15. pii: 10.1245/s10434-020-09521.
    PubMed     Abstract available
    
    
    
86. VAN VEENENDAAL LM, Bertolli E, Korse CM, Klop WMC, et al
    The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC).
    Ann Surg Oncol. 2021;28:1019-1028.
    PubMed     Abstract available
    
    
    January 2021
87. LI S, Wu N
    ASO Author Reflections: Proposed Nodal Categories for Future Editions of the TNM Classification of Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Jan 9. pii: 10.1245/s10434-020-09516.
    PubMed    
    
    
    
88. LI S, Yan S, Lu F, Lv C, et al
    Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2021 Jan 2. pii: 10.1245/s10434-020-09461.
    PubMed     Abstract available
    
    
    
89. SHIGEFUKU S, Shimada Y, Hagiwara M, Kakihana M, et al
    Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:148-156.
    PubMed     Abstract available
    
    
    
90. SHIGEFUKU S, Shimada Y
    ASO Author Reflections: Impact of Ground-Glass Opacity Components in Long-Term Survivors with Resected Lung Adenocarcinoma.
    Ann Surg Oncol. 2021;28:157-158.
    PubMed    
    
    
    
91. OHTSUKA T
    Importance of Ground-Glass Opacity in Long-Term Survivors of Lung Adenocarcinoma: A Leopard Cannot Change Its Spots.
    Ann Surg Oncol. 2021;28:14-15.
    PubMed    
    
    
    December 2020
92. LEINWAND JC, Kluger MD
    ASO Author Reflections: Improving Outcomes in Diffuse Malignant Peritoneal Mesothelioma: Challenges and Opportunities.
    Ann Surg Oncol. 2020;27.
    PubMed    
    
    
    November 2020
93. ZUO Z, Zhang G, Song P, Yang J, et al
    Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
    Ann Surg Oncol. 2020 Nov 28. pii: 10.1245/s10434-020-09362.
    PubMed     Abstract available
    
    
    
94. YAMAMOTO H, Yamamoto H, Soh J, Suzuki E, et al
    A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
    Ann Surg Oncol. 2020 Nov 24. pii: 10.1245/s10434-020-09272.
    PubMed     Abstract available
    
    
    
95. YAMAMOTO H, Yamamoto H, Toyooka S
    A New Scoring System for Predicting the Survival of Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score.
    Ann Surg Oncol. 2020 Nov 4. pii: 10.1245/s10434-020-09299.
    PubMed    
    
    
    October 2020
96. EBY M, Seder CW
    Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al.
    Ann Surg Oncol. 2020 Oct 26. pii: 10.1245/s10434-020-09258.
    PubMed    
    
    
    
97. KUMAR N, Bhoriwal S, Kumar S
    Letter to the Editor of Annals of Surgical Oncology Concerning "The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer".
    Ann Surg Oncol. 2020 Oct 22. pii: 10.1245/s10434-020-09249.
    PubMed    
    
    
    
98. MATSUBARA T, Takamori S, Haratake N, Fujishita T, et al
    Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
    Ann Surg Oncol. 2020 Oct 21. pii: 10.1245/s10434-020-09230.
    PubMed     Abstract available
    
    
    
99. KANZAKI R
    ASO Author Reflections: Long-Term Outcomes of Pulmonary Metastasectomy for Uterine Malignancies: A Multi-institutional Study in the Current Era.
    Ann Surg Oncol. 2020;27:3829-3830.
    PubMed    
    
    
    
100. TANG WF, Zhong WZ
     ASO Author Reflections: Lung Adenocarcinoma with Accidental Invisible Pleural Dissemination Lesions: Wait-and-See Strategy for Tumors with Indolent Biologic Characteristics.
     Ann Surg Oncol. 2020;27:3819-3820.
     PubMed    
     
     
     
101. JUNG W, Cho S, Yum S, Chung JH, et al
     Stepwise Disease Progression Model of Subsolid Lung Adenocarcinoma with Cystic Airspaces.
     Ann Surg Oncol. 2020;27:4394-4403.
     PubMed     Abstract available
     
     
     
102. TSAI PC, Yeh YC, Hsu PK, Chen CK, et al
     CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.
     Ann Surg Oncol. 2020;27:4405-4412.
     PubMed     Abstract available
     
     
     
103. DEMMY TL
     The Musician, Instrument, or Orchestra?
     Ann Surg Oncol. 2020;27:4088-4090.
     PubMed    
     
     
     
104. JUNG W, Cho S
     ASO Author Reflections: Understanding Subsolid Lung Adenocarcinoma with Cystic Airspaces (LACA).
     Ann Surg Oncol. 2020;27:4404.
     PubMed    
     
     
     September 2020
105. CHEN D, Ding Q, Wang W, Chen C, et al
     ASO Author Reflections: Old Song, New Sung-Extracapsular Extension in Lung Cancer in the Era of Eighth-Edition N Classification.
     Ann Surg Oncol. 2020 Sep 22. pii: 10.1245/s10434-020-09173.
     PubMed    
     
     
     
106. WANKHEDE D
     Evaluation of Eighth AJCC TNM Sage for Lung Cancer NSCLC: A Meta-analysis.
     Ann Surg Oncol. 2020 Sep 20. pii: 10.1245/s10434-020-09151.
     PubMed     Abstract available
     
     
     
107. CHEN Y, Zhang J, Chen L, Dai J, et al
     Lymph Node Examination for Stage I Second Primary Lung Cancer Patients Who Received Second Surgical Treatment.
     Ann Surg Oncol. 2020 Sep 5. pii: 10.1245/s10434-020-08975.
     PubMed     Abstract available
     
     
     August 2020
108. ZHU Y, Liu L
     ASO Author Reflections: A Novel Concept to Decreasing the Technical Difficulty of Complex Pulmonary Segmentectomy.
     Ann Surg Oncol. 2020;27:3094-3095.
     PubMed    
     
     
     July 2020
109. MASCALCHI M
     Lung Cancer Associated with Cystic Airspaces in the Screening Perspective.
     Ann Surg Oncol. 2020 Jul 22. pii: 10.1245/s10434-020-08929.
     PubMed    
     
     
     
110. LIU C, Wei S, Liu L
     ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node.
     Ann Surg Oncol. 2020 Jul 20. pii: 10.1245/s10434-020-08876.
     PubMed    
     
     
     
111. TAKAMORI S, Shimokawa M, Matsubara T, Haratake N, et al
     Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2020 Jul 16. pii: 10.1245/s10434-020-08851.
     PubMed     Abstract available
     
     
     
112. YANG Y, Mei J, Lin F, Pu Q, et al
     Comparison of the Short- and Long-term Outcomes of Video-assisted Thoracoscopic Surgery versus Open Thoracotomy Bronchial Sleeve Lobectomy for Central Lung Cancer: A Retrospective Propensity Score Matched Cohort Study.
     Ann Surg Oncol. 2020 Jul 8. pii: 10.1245/s10434-020-08805.
     PubMed     Abstract available
     
     
     
113. TAKAMORI S, Okamoto T, Mori M
     ASO Author Reflections: Which of Smoking Duration or Smoking Intensity Contributes to Poor Prognosis After Resection of Non-small Cell Lung Cancer?
     Ann Surg Oncol. 2020 Jul 8. pii: 10.1245/s10434-020-08852.
     PubMed    
     
     
     
114. LIU C, Wei S, Guo C, Mei J, et al
     Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
     Ann Surg Oncol. 2020 Jul 7. pii: 10.1245/s10434-020-08786.
     PubMed     Abstract available
     
     
     June 2020
115. ZHANG Y, Li G, Li Y, Liu Q, et al
     Imaging Features Suggestive of Multiple Primary Lung Adenocarcinomas.
     Ann Surg Oncol. 2020;27:2061-2070.
     PubMed     Abstract available
     
     
     
116. WANG C, Yang J, Lu M
     Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy.
     Ann Surg Oncol. 2020;27:2051-2060.
     PubMed     Abstract available
     
     
     
117. KINOSHITA F, Takada K, Yamada Y, Oku Y, et al
     Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
     Ann Surg Oncol. 2020;27:2102-2109.
     PubMed     Abstract available
     
     
     May 2020
118. EBY ME, Seder CW
     The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer.
     Ann Surg Oncol. 2020 May 9. pii: 10.1245/s10434-020-08553.
     PubMed    
     
     
     
119. BEKHOR E, Carr J, Hofstedt M, Sullivan B, et al
     The Safety of Iterative Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis: A High Volume Center Prospectively Maintained Database Analysis.
     Ann Surg Oncol. 2020;27:1448-1455.
     PubMed     Abstract available
     
     
     April 2020
120. ZHANG X, Moriwaki T, Kawabata T, Goto S, et al
     Nicaraven Attenuates Postoperative Systemic Inflammatory Responses-Induced Tumor Metastasis.
     Ann Surg Oncol. 2020;27:1068-1074.
     PubMed     Abstract available
     
     
     March 2020
121. CHIANG XH, Hsu HH, Hsieh MS, Chang CH, et al
     Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
     Ann Surg Oncol. 2020;27:703-715.
     PubMed     Abstract available
     
     
     
122. CHIANG XH, Lin MW, Chen JS
     Indication for Sublobar Resection in cT1N0 Lung Adenocarcinoma is Contentious.
     Ann Surg Oncol. 2020;27:956-957.
     PubMed    
     
     
     
123. KISHI N, Ito M, Miyata Y, Kanai A, et al
     Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component.
     Ann Surg Oncol. 2020;27:945-955.
     PubMed     Abstract available
     
     
     
124. LIN MW, Chen JS
     ASO Author Reflections: Sublobar Resection En Route to Becoming the Standard of Care for cT1N0 Lung Adenocarcinoma.
     Ann Surg Oncol. 2020;27:716-717.
     PubMed    
     
     
     February 2020
125. BOEDING JRE, Schreinemakers JMJ
     ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
     Ann Surg Oncol. 2020 Feb 11. pii: 10.1245/s10434-020-08250.
     PubMed    
     
     
     January 2020
126. LETICA-KRIEGEL AS, Leinwand JC, Sonett JR, Gorenstein LA, et al
     50 Patients with Malignant Mesothelioma of Both the Pleura and Peritoneum: A Single-Institution Experience.
     Ann Surg Oncol. 2020;27:205-213.
     PubMed     Abstract available
     
     
     December 2019
127. BROUWER NPM, van der Kruijssen DEW, Hugen N, de Hingh IHJT, et al
     The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.
     Ann Surg Oncol. 2019 Dec 2. pii: 10.1245/s10434-019-08100.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: